Global Collaboration Strengthens Understanding of Primary Ciliary Dyskinesia

A growing global effort is underway to better understand the lived experiences of people affected by Primary Ciliary Dyskinesia (PCD), as international organisations join forces to engage directly with the patient community through targeted surveys.

PCD, a rare genetic condition that affects the respiratory system and other organs, remains underdiagnosed and often misunderstood. To address this, leading organisations—including PCD Foundation, PCD Support UK, and BEAT-PCD—are collaborating with national bodies such as PCD Australia to gather critical insights from patients and families worldwide.

These surveys aim to capture real-world data on a range of issues impacting the PCD community, including access to specialist care, diagnostic pathways, treatment burdens, mental health, and quality of life. By hearing directly from those living with the condition, organisations hope to identify gaps in care, highlight disparities between regions, and advocate for improved services and support systems.

“This global approach is essential,”. “While PCD is rare, the challenges faced by patients are shared across borders. By working together and amplifying patient voices, we can build a clearer picture of what needs to change.”

The initiative also reflects a broader shift toward patient-centred research, where individuals are not just subjects of study but active contributors shaping the direction of research and care. Data collected from these surveys will inform future clinical guidelines, research priorities, and policy advocacy efforts.

For countries like Australia, participation in global surveys ensures that local experiences are represented on the international stage. Organisations such as PCD Australia play a key role in encouraging community engagement and ensuring that the unique challenges faced by Australian patients—particularly those in rural and regional areas—are not overlooked.

Ultimately, this collaborative effort marks a significant step forward in raising awareness of PCD and strengthening the global response to rare diseases. By uniting organisations and empowering patients to share their stories, the PCD community is working toward a future of earlier diagnosis, better treatments, and improved quality of life for all those affected.

The current study is “Living with PCD”.  Below for more about the Study and link 

https://pcd.ispm.ch/en/study-info/